Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Production / Operations

Birchtech Issues Shareholder Letter and Provides Corporate Update

BCHT · Price

Executive Summary

  • Birchtech secured a final federal court judgment of approximately $78 million in its patent infringement case and is initiating collection.
  • The company completed a $15 million capital raise concurrent with its uplisting to NYSE American and a reverse stock split, strengthening the balance sheet for water‑treatment expansion.
  • Birchtech outlined significant growth initiatives—including licensing revenue of ~$37 million since 2020, upcoming construction of a GAC rejuvenation facility (expected online late 2027), and multiple pilot programs targeting PFAS removal—positioning 2026 as a milestone year for both clean‑air and water‑treatment segments.

Key Details

  • Litigation Success: U.S. District Court increased judgment to ~$78 M against refined‑coal operators; collection process underway despite pending appeal.
  • Licensing Revenue: Cumulative $37 M in license fees and settlements received since 2020 from utility licensing agreements for the SEA® mercury capture technology.
  • Capital Markets Milestones:
  • Executed a reverse stock split (date not specified).
  • Uplisted to NYSE American on Feb 26 2026, enhancing visibility and liquidity.
  • Completed a $15 M equity raise in December 2025/early 2026, earmarked for water‑business expansion and Carbon Rejuvenation™ infrastructure.
  • Water‑Treatment Growth:
  • Ongoing media changeout projects; purchase orders totalling ~$0.9 M from a mid‑Atlantic utility for wastewater filtration media replacement (announced Oct 2025).
  • Pilot programs with universities (Rapid Small‑Scale Column Testing) targeting multi‑year carbon supply opportunities starting in 2027.
  • Targeting ~50,000 U.S. community water systems, especially small‑ to mid‑size utilities facing PFAS, arsenic, selenium, mercury compliance pressures.
  • Carbon Rejuvenation™ Initiative: Demonstrated thermally rejuvenated GAC (rGAC) performance comparable to virgin carbon for PFAS removal; construction of first rGAC facility slated for 2026 with commissioning expected late 2027.
  • Operational Highlights: Near‑doubling of staffing in technical and operational roles; design centers positioned to become meaningful revenue contributors beginning in 2026.
  • Outlook for 2026: Anticipated continued licensing activity, product supply agreements, and advancement of water‑treatment pilot programs; expects the rejuvenation facility and expanded service offerings to generate recurring revenue streams.

Notable Quotes

“We entered 2026 positioned for continued expansion in water treatment and long‑term value creation.” – Richard MacPherson, CEO, Birchtech Corp.

Read the original news release →

More from BIRCHTECH CORP